Delivery Order SPE2DB22D3401-SPE2DB24FT1EN
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $11,805.82 firm fixed price contract is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has a completion date of January 25, 2024. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA to supply...
- This federal contract award, valued at $38,542.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VRAYLAR 3 MG CAPSULE 30S. The contract is a firm fixed-price delivery order with an ultimate completion date of August 30, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor, and there is no set-aside designation for this award. This contract is likely part of a larger...
- This federal contract award, valued at $5,318.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. This is a firm-fixed-price delivery order contract with a completion date of September 20, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $15,685.92 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of September 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $1,978.52 with Amerisourcebergen Drug Corp as the prime contractor. The award is for the supply of VRAYLAR 1.5 MG capsules in quantities of 30, with a completion date of February 18, 2025. The contract is a firm fixed-price arrangement without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a key vendor for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,494.63, is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a specialty medication. This is a firm fixed-price delivery order contract with an ultimate completion date of April 11, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $19,943.84 firm fixed price delivery order is for the supply of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product. The contract has a completion date of January 16, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has received numerous federal...
- This federal contract award, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,625.35 firm fixed-price delivery order is to provide VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The $4,426.60 contract has a performance period through March 5, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger $999,999,999.00 indefinite...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order issued to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $6,419.20, is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of August 30, 2024 and uses a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug Corporation is a major supplier of...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB24FT1ENDelivery Order
This federal contract award is a $5,043.78 firm fixed price delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a completion date of January 4, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, has previously received numerous federal contracts from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities. The company's Corporate Office division provides these products and services to U.S. government agencies, primarily the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 1/3/24 |